解决中国扩大人乳头瘤病毒疫苗接种的障碍:进展和前进方向。

IF 8.1 1区 医学
Xue-Lian Zhao, Shang-Ying Hu, Jia-Wei Hu, Hong-Hao Wang, Tian-Meng Wen, Yu-Shu Feng, You-Lin Qiao, Fang-Hui Zhao, Yong Zhang
{"title":"解决中国扩大人乳头瘤病毒疫苗接种的障碍:进展和前进方向。","authors":"Xue-Lian Zhao, Shang-Ying Hu, Jia-Wei Hu, Hong-Hao Wang, Tian-Meng Wen, Yu-Shu Feng, You-Lin Qiao, Fang-Hui Zhao, Yong Zhang","doi":"10.1186/s40249-023-01136-6","DOIUrl":null,"url":null,"abstract":"<p><p>The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based evidence, promoting free HPV vaccination from pilots, and launching action plans to tackle barriers in the scale-up of HPV vaccination. To further roll out the HPV vaccination program in China, several challenges should be addressed to support the steps forward. The availability of more locally manufactured HPV vaccines, pricing negotiation and local evidence supporting the efficacy of one-dose schedule would greatly alleviate the continued supply and financial constraints in China. Meanwhile, more attention should be paid to girls living in low-resource areas and males to ensure equal access to the HPV vaccination. Furthermore, linkage to secondary prevention and further real-world monitoring and evaluation are warranted to inform effective cervical cancer prevention strategies in the post-vaccine era.</p>","PeriodicalId":48820,"journal":{"name":"Infectious Diseases of Poverty","volume":"12 1","pages":"86"},"PeriodicalIF":8.1000,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512493/pdf/","citationCount":"0","resultStr":"{\"title\":\"Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.\",\"authors\":\"Xue-Lian Zhao, Shang-Ying Hu, Jia-Wei Hu, Hong-Hao Wang, Tian-Meng Wen, Yu-Shu Feng, You-Lin Qiao, Fang-Hui Zhao, Yong Zhang\",\"doi\":\"10.1186/s40249-023-01136-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based evidence, promoting free HPV vaccination from pilots, and launching action plans to tackle barriers in the scale-up of HPV vaccination. To further roll out the HPV vaccination program in China, several challenges should be addressed to support the steps forward. The availability of more locally manufactured HPV vaccines, pricing negotiation and local evidence supporting the efficacy of one-dose schedule would greatly alleviate the continued supply and financial constraints in China. Meanwhile, more attention should be paid to girls living in low-resource areas and males to ensure equal access to the HPV vaccination. Furthermore, linkage to secondary prevention and further real-world monitoring and evaluation are warranted to inform effective cervical cancer prevention strategies in the post-vaccine era.</p>\",\"PeriodicalId\":48820,\"journal\":{\"name\":\"Infectious Diseases of Poverty\",\"volume\":\"12 1\",\"pages\":\"86\"},\"PeriodicalIF\":8.1000,\"publicationDate\":\"2023-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512493/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious Diseases of Poverty\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40249-023-01136-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases of Poverty","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40249-023-01136-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

人乳头瘤病毒(HPV)疫苗是第一种专门针对预防癌症而开发的疫苗。15年多来,中国加快了一系列国产HPV疫苗的研发工作,提供了基于当地人群的证据,推广了试点免费HPV疫苗接种,并启动了解决扩大HPV疫苗接种障碍的行动计划。为了在中国进一步推广HPV疫苗接种计划,应解决几个挑战,以支持向前迈出的步伐。更多本地生产的HPV疫苗的可用性、价格谈判和支持一剂计划有效性的本地证据将大大缓解中国持续的供应和财政限制。同时,应更多地关注生活在低资源地区的女孩和男性,以确保平等获得HPV疫苗接种。此外,有必要将二级预防与进一步的现实世界监测和评估联系起来,为后疫苗时代有效的癌症预防策略提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward.

The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting the prevention of cervical cancer. For more than 15 years, China has expedited a series of efforts on research and development of the domestically manufactured HPV vaccines, producing local population-based evidence, promoting free HPV vaccination from pilots, and launching action plans to tackle barriers in the scale-up of HPV vaccination. To further roll out the HPV vaccination program in China, several challenges should be addressed to support the steps forward. The availability of more locally manufactured HPV vaccines, pricing negotiation and local evidence supporting the efficacy of one-dose schedule would greatly alleviate the continued supply and financial constraints in China. Meanwhile, more attention should be paid to girls living in low-resource areas and males to ensure equal access to the HPV vaccination. Furthermore, linkage to secondary prevention and further real-world monitoring and evaluation are warranted to inform effective cervical cancer prevention strategies in the post-vaccine era.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Infectious Diseases of Poverty
Infectious Diseases of Poverty INFECTIOUS DISEASES-
自引率
1.20%
发文量
368
期刊介绍: Infectious Diseases of Poverty is an open access, peer-reviewed journal that focuses on addressing essential public health questions related to infectious diseases of poverty. The journal covers a wide range of topics including the biology of pathogens and vectors, diagnosis and detection, treatment and case management, epidemiology and modeling, zoonotic hosts and animal reservoirs, control strategies and implementation, new technologies and application. It also considers the transdisciplinary or multisectoral effects on health systems, ecohealth, environmental management, and innovative technology. The journal aims to identify and assess research and information gaps that hinder progress towards new interventions for public health problems in the developing world. Additionally, it provides a platform for discussing these issues to advance research and evidence building for improved public health interventions in poor settings.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信